FindTrial
Sign In

Exploring the Effectiveness of Synbiotics in Treating Allergic Rhinitis

Unveiling the potential of symbiotics in allergic rhinitis treatment: A multi-arm double blinded randomized control trial. - NIL

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/01/079358
Enrollment
165
Registered
2025-01-24
Start date
Unknown
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J309- Allergic rhinitis, unspecified

Interventions

Intervention1: Synbiotics: Synbiotics (Pre + Probiotics) in oral formulation for 3 months Control Intervention1: Prebiotics & Probiotics: Prebiotics in the oral formulation for 3 months Probiotics in

Sponsors

PES University Institute of Medical Sciences Research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Individuals who are aged above 18 years. 2. Individuals suffering from perennial allergic rhinitis. 3. Participants who are willing to participate.

Exclusion criteria

Exclusion criteria: 1. Individuals with nasal polyposis. 2. Participants with concurrent comorbidities. 3. Migrants to the place of study who migrated less than an year ago.

Design outcomes

Primary

MeasureTime frame
Decrease in Allergic symptoms assessed using SNOT 20, Absolute Eosinophilic count and IgE levels.Timepoint: Participants will be assessed at 1, 3 and 6 months duration.—

Secondary

MeasureTime frame
AEC Ige counts will reduceTimepoint: measured at 3rd and 6th month—

Countries

India

Contacts

Public ContactSmitha Chandra B C

Department of ENT & HNS

smithachandra10@gmail.com7259511715

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026